Cibus, Inc. — Director's Dealing 2019

Feb 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2019-01-31

Reporting Person: Voytas Daniel F (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-31	Common Stock	M	4083	$3.7143	Acquired	97065	Direct
2019-01-31	Common Stock	S	4083	$13.00	Disposed	92982	Direct
2019-02-01	Common Stock	M	4087	$3.7143	Acquired	97069	Direct
2019-02-01	Common Stock	S	4087	$13.00	Disposed	92982	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-31	Stock Option (Right to Buy)	$3.7143	M	4083	Disposed	2024-12-03	Common Stock (4083)	Direct
2019-02-01	Stock Option (Right to Buy)	$3.7143	M	4087	Disposed	2024-12-03	Common Stock (4087)	Direct

Footnotes

F1: Includes 85,443 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 15,078 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F3: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on December 3, 2014 and vested 20% on January 3, 2015 and 20% on April 10, 2015, with the remainder vested quarterly in equal installments thereafter, 15% of which vested immediately on July 25, 2017 when Calyxt, Inc. underwent its initial public offering.